Evidence map›Paper›PMID 39779626›Full record

ArticleAIDS and behavior2025

Understanding Awareness, Utilization, and the Awareness-Utilization Gap of HIV PrEP and nPEP Among Young MSM in China.

Jingtao Zhou, Yutong Xu, Qingyu Li, Yuhang Zhang, Siwen Huang, Jiaruo Sun, Jiayin Zheng, Yan Li, Yongkang Xiao, Wei Ma and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jingtao ZhouVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Yutong XuVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Qingyu LiVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Yuhang ZhangVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Siwen HuangVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Jiaruo SunVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Jiayin ZhengVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Yan LiGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, 511430, China.
Yongkang XiaoDepartment of Acute Infectious Diseases Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, 230601, China.
Wei MaDepartment of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250102, China.
Lin HeZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, 310057, China.
Xianlong RenDepartment of AIDS/STD Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, 100013, China.
Zhen DaiDepartment of AIDS/STD Control and Prevention, Chengdu Center for Disease Control and Prevention, Chengdu, Sichuan, 610044, China.
Hui XueBlued Health, Beijing, 100020, China.
Feng ChengVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Wannian LiangVanke School of Public Health, Tsinghua University, Beijing, 100084, China.
Sitong LuoVanke School of Public Health, Tsinghua University, Beijing, 100084, China. sitongluo@tsinghua.edu.cn.ORCID http://orcid.org/0000-0002-7450-5613

Funding

Beijing Municipal Health Commission 2024-2G-4402Vanke School of Public Health, Tsinghua University 100010001
6 · The paper itself

Abstract

HIV/AIDS remains a significant public health challenge in China, particularly among men who have sex with men (MSM). Pre-Exposure Prophylaxis (PrEP) and non-occupational post-exposure Prophylaxis (nPEP) are effective interventions to reduce HIV transmission in high-risk populations. This study assessed awareness and utilization levels of PrEP and nPEP among young MSM (YMSM) aged 18-29 in China and examined associated factors. A cross-sectional survey of 2,493 YMSM was conducted across six Chinese provinces in September 2022. Participants, recruited via facility-based sampling, completed self-administered online questionnaires distributed by MSM-oriented community-based organizations. Of all the participants, 2,278 (91.4%) were aware of PrEP, and 220 (8.8%) had ever used PrEP; 2,321 (93.1%) were aware of nPEP, and 209 (8.4%) had ever used nPEP. Education level and having recent male sexual partners were positively associated with awareness of PrEP and nPEP, while self-stigma was negatively associated with awareness for both. Among those who had head of PrEP or nPEP, age, having more than 2 male sex partners, and having a history of sexually transmitted diseases (STD) infection were positively associated with the utilization of PrEP and nPEP; inconsistent condom use was associated with less PrEP utilization; monthly income was positively associated with nPEP utilization. Despite high awareness levels, the low utilization of PrEP and nPEP highlights missed opportunities for HIV prevention. Strengthening education on their importance, promoting condom use alongside PrEP/nPEP, reducing stigma, and addressing financial barriers are critical steps toward improving HIV prevention strategies and empowering YMSM to engage with these life-saving interventions.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsHomosexuality, MalePatient Acceptance of Health CarePost-Exposure ProphylaxisPre-Exposure ProphylaxisAdolescentAdultChinaCross-Sectional StudiesHumansMaleSexual PartnersSocial StigmaSurveys and QuestionnairesYoung AdultChinaHIV/AIDSnPEPPrEPYoung men who have sex with men

Identifiers

PMID39779626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.